Search
for
Sort by
Research 61–90 of 180
- Enhanced Follicular Delivery of Finasteride to Human Scalp Skin Using Heat and Chemical Penetration Enhancers
- An update on diagnosis and treatment of female pattern hair loss
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Hair aging and anti-aging
- Debatable Topics in PCOS Patients
- Contraindicated use of 5-alpha-reductase inhibitors in women
- Compounding as a Current Therapeutic Option in Dermatology
- IMPACT OF POLY CYSTIC OVARIAN SYNDROME ON THE QUALITY OF LIFE OF MARRIED FEMALES: A CROSS-SECTIONAL STUDY
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Androgen excess: a hallmark of polycystic ovary syndrome
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Postmenopausal Alopecia (Hair Loss)
- Androgenetska alopecija u žena
- Alopecia: managing the basics
- Hormonal Treatment for Skin Androgen-Related Disorders
- Системная терапия больных андрогенетической алопецией
- Polycystic Ovary Syndrome
- Cutaneous manifestations of polycystic ovary syndrome
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- Das polyzystische Ovarsyndrom: Aktuelle Evidenz und praktische Empfehlungen
- Unravelling the link between insulin resistance and androgen excess
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
- Evidence-based approach to cutaneous hyperandrogenism in women
- Hormone und Haarwachstum
- The association of androgenetic alopecia and insulin resistance is independent of hyperandrogenemia: A case-control study
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Androgenisierung
- The frequency of polycystic ovary syndrome in women with prediabetes compared with normoglycemic women